LAMATTINA JOHN L 4
4 · LIGAND PHARMACEUTICALS INC · Filed Dec 27, 2022
Insider Transaction Report
Form 4
LAMATTINA JOHN L
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2022-12-22+4,484→ 4,484 totalExercise: $67.03Exp: 2032-12-22→ Common Stock (4,484 underlying)
Footnotes (1)
- [F1]Grant to reporting person of stock options that will vest and become exercisable on December 22, 2023.